John is a Scientific Advisor for Poseidon. John co-invented antibody phage display and was a co-founder of Cambridge Antibody Technology (developers of the blockbuster drug adalimumab, brand name Humira). John has also headed research groups at the Wellcome Trust Sanger Institute and the Department of Biochemistry at the University of Cambridge. More recently, John founded Iontas Ltd. and is CTO of Maxion Therapeutics.